0PUQ4JZ
Supplement Metacarpal, Left to No Qualifier with Synthetic Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | P Upper Bones |
| Operation | U Supplement |
| Body Part | Q Metacarpal, Left |
| Approach | 4 Percutaneous Endoscopic |
| Device | J Synthetic Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures add biological or synthetic material to reinforce or augment a bone of the skull, face, thorax, or upper limb that remains anatomically in place, rather than replacing or repairing damaged tissue. Common examples include bone grafting to reinforce a weakened area of the skull, or augmenting a thin area of the sternum or scapula with mesh or cement to add structural strength.
This approach is chosen when the native bone is largely intact and functional but needs extra support, often to prevent future fracture, to build up bone stock before another procedure, or to strengthen a surgical repair site.
Anatomy & Axis Detail
Metacarpal, Left
In the left hand, metacarpal supplementation is typically performed to address a bony void left after resection of a tumor, debridement of an infected nonunion, or reduction of a severely comminuted fracture that has resulted in bone loss. The surgeon packs the defect with autograft, allograft, or a synthetic substitute to reestablish the shaft's normal length and cross-sectional area, since even modest shortening of a metacarpal can alter the mechanical balance of the hand and produce a noticeable extensor lag or grip weakness. Because the metacarpals form the rigid base from which the fingers move, restoring their structural integrity is prioritized before addressing any residual soft tissue imbalance. This procedure is commonly documented alongside concurrent internal fixation, but the graft placement itself is what qualifies as the supplementing procedure for coding purposes.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Synthetic Substitute
Synthetic Substitute designates a device made from manufactured, non-biologic material, such as mesh or prosthetic components, used to replace or augment a body part. It is distinguished from the two tissue substitute categories by its artificial composition, which carries different considerations for integration and long-term durability than biologic grafts.
Coding & Documentation
Coders should confirm the operative note describes material being added to reinforce a structure that stays in place, not material substituting for a removed part. The device or graft type documented determines the correct device value - autograft, allograft, synthetic substitute, or nonautologous tissue - so vague documentation of "bone graft" without a source can complicate accurate coding. A common mistake is coding supplement when the surgeon actually performed a replacement, particularly in cranioplasty cases where it's unclear whether native bone was removed first. Another frequent error is missing a supplement code entirely when a graft was placed during a repair or reposition procedure, since it may require a separate code rather than being bundled in.